{"cik":2096997,"taxonomy":"us-gaap","tag":"OtherAssetsCurrent","label":"Other Assets, Current","description":"Amount of current assets classified as other.","entityName":"Kailera Therapeutics, Inc.","units":{"USD":[{"end":"2025-12-31","val":1234000,"accn":"0001193125-26-239417","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26"},{"end":"2025-12-31","val":1502000,"accn":"0001193125-26-346958","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2025Q4I"},{"end":"2026-03-31","val":360000,"accn":"0001193125-26-239417","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-26","frame":"CY2026Q1I"},{"end":"2026-06-30","val":395000,"accn":"0001193125-26-346958","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2026Q2I"}]}}